Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in Multiple System Atrophy
NCT04431713Phase 2Completed
- Sponsor
- University College London
- Start
- Sep 2020
- Primary completion
- Mar 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in multiple system atrophy (MSA), sponsored by University College London. Started Sep 2020; status: completed.
02
Drugs
exenatide
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT04431713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04431713.